相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。c-Myc Accelerates S-Phase and Requires WRN to Avoid Replication Stress
Kristin Robinson et al.
PLOS ONE (2009)
Identification of CDK2 substrates in human cell lysates
Yong Chi et al.
GENOME BIOLOGY (2008)
Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis
Everardo Macias et al.
CANCER RESEARCH (2007)
Global chromatin compaction limits the strength of the DNA damage response
Matilde Murga et al.
JOURNAL OF CELL BIOLOGY (2007)
HIF-dependent antitumorigenic effect of antioxidants in vivo
Ping Gao et al.
CANCER CELL (2007)
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response
Chiara Gorrini et al.
NATURE (2007)
Cdk1 is sufficient to drive the mammalian cell cycle
David Santamaria et al.
NATURE (2007)
Non-transcriptional control of DNA replication by c-Myc
David Dominguez-Sola et al.
NATURE (2007)
Atm deficiency affects both apoptosis and proliferation to augment myc-induced lymphomagenesis
Kirsteen H. Maclean et al.
MOLECULAR CANCER RESEARCH (2007)
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Andrei Goga et al.
NATURE MEDICINE (2007)
Short telomeres limit tumor progression in vivo by inducing senescence
David M. Feldser et al.
CANCER CELL (2007)
Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence
Wilfredo Cosme-Blanco et al.
EMBO REPORTS (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase
Sathyavageeswaran Shreeram et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers
Andrew J. Deans et al.
CANCER RESEARCH (2006)
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species
Suma Ray et al.
CANCER RESEARCH (2006)
CDK2 is required by MYC to induce apoptosis
Debabrita Deb-Basu et al.
CELL CYCLE (2006)
MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of Cyclin E/CDK2
Debabrita Deb-Basu et al.
CELL CYCLE (2006)
ATM promotes apoptosis and suppresses tumorigenesis in response to Myc
RV Pusapati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
MT Hemann et al.
NATURE (2005)
Cdc2-cyclin E complexes regulate the G1/S phase transition
E Aleem et al.
NATURE CELL BIOLOGY (2005)
c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus
SF Louis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27Kip1 and p21Cip1
A Martín et al.
CANCER CELL (2005)
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation
JA Nilsson et al.
CANCER CELL (2005)
Cyclin-dependent kinases regulate the antiproliferative function of Smads
I Matsuura et al.
NATURE (2004)
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation
RA Woo et al.
GENES & DEVELOPMENT (2004)
Cdk2 knockout mice are viable
C Berthet et al.
CURRENT BIOLOGY (2003)
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
S Ortega et al.
NATURE GENETICS (2003)
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
S Parrinello et al.
NATURE CELL BIOLOGY (2003)
Werner syndrome protein limits MYC-induced cellular senescence
C Grandori et al.
GENES & DEVELOPMENT (2003)
Proliferation of cancer cells despite CDK2 inhibition
O Tetsu et al.
CANCER CELL (2003)
Loss of p27Kip1 but not p21Cip1 decreases survival and synergizes with MYC in murine lymphomagenesis
CP Martins et al.
EMBO JOURNAL (2002)
Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression
S Pelengaris et al.
CELL (2002)
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
CA Schmitt et al.
CELL (2002)
c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability
O Vafa et al.
MOLECULAR CELL (2002)
Dissecting p53 tumor suppressor functions in vivo
CA Schmitt et al.
CANCER CELL (2002)
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
P Krimpenfort et al.
NATURE (2001)
Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts
DW Felsher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
